We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$4.15B
AUM Growth
-$3.94B
Cap. Flow
-$4.44B
Cap. Flow %
-106.94%
Top 10 Hldgs %
33.3%
Holding
6,378
New
470
Increased
1,548
Reduced
3,513
Closed
532

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$263M
2
AAPL icon
Apple
AAPL
+$226M
3
AMZN icon
Amazon
AMZN
+$127M
4
NVDA icon
NVIDIA
NVDA
+$115M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$80.9M

Sector Composition

Rank Sector Weight
1 Technology 26.16%
2 Consumer Discretionary 9.21%
3 Communication Services 8.49%
4 Financials 7.96%
5 Industrials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAMT icon
5876
Camtek
CAMT
$7.51B
-445
Closed -$30.9K
CBUS icon
5877
Cibus
CBUS
$145M
-1,145
Closed -$22.5K
CEE
5878
Central and Eastern Europe Fund
CEE
$137M
-11
Closed -$107
CGDV icon
5879
Capital Group Dividend Value ETF
CGDV
$38.9B
-5,983
Closed -$179K
CGEN icon
5880
Compugen
CGEN
$223M
-3,114
Closed -$6.17K
CHRS icon
5881
Coherus Oncology
CHRS
$193M
-13,003
Closed -$43.3K
CLMB icon
5882
Climb Global Solutions
CLMB
$512M
-2,020
Closed -$27.7K
COCH icon
5883
Envoy Medical
COCH
$54.1M
-1,714
Closed -$3.1K
COMB icon
5884
GraniteShares Bloomberg Commodity Broad Strategy No K-1 ETF
COMB
$151M
-114
Closed -$2.21K
COWZ icon
5885
Pacer US Cash Cows 100 ETF
COWZ
$19.6B
-40,872
Closed -$2.12M
COYA icon
5886
Coya Therapeutics
COYA
$108M
-3,344
Closed -$24.8K
CPER icon
5887
United States Copper Index Fund
CPER
$778M
-1
Closed -$24
CRAI icon
5888
CRA International
CRAI
$1.07B
-3,857
Closed -$381K
CREG
5889
DELISTED
Smart Powerr
CREG
-3
Closed -$498
CRT
5890
Cross Timbers Royalty Trust
CRT
$60.1M
-235
Closed -$4.13K
CRVO icon
5891
CervoMed
CRVO
$26.6M
-725
Closed -$5.53K
CTEC icon
5892
Global X ClimateTech ETF
CTEC
$25.5M
-332
Closed -$18K
CTMX icon
5893
CytomX Therapeutics
CTMX
$745M
-7,184
Closed -$11.1K
CYD icon
5894
China Yuchai International
CYD
$1.76B
-33
Closed -$277
CYRX icon
5895
CryoPort
CYRX
$757M
-7,553
Closed -$117K
CZWI icon
5896
Citizens Community Bancorp
CZWI
$196M
-1,164
Closed -$13.6K
DADA
5897
DELISTED
Dada Nexus
DADA
-21,338
Closed -$70.8K
DBC icon
5898
Invesco DB Commodity Index Tracking Fund
DBC
$1.72B
-140
Closed -$3.09K
DBE icon
5899
Invesco DB Energy Fund
DBE
$90.2M
-2,423
Closed -$46.5K
DBL
5900
DoubleLine Opportunistic Credit Fund
DBL
$281M
-220
Closed -$3.38K

Similar funds

Tower Research Capital (TRC)'s Q1 2024 Portfolio in Review

As of Q1 2024, Tower Research Capital (TRC) held 6,378 positions worth $4.15B, down 49% from $8.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.44B in Q1 2024, closing 532 positions and reducing 3,513 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $49.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares S&P Small-Cap 600 Growth ETF worth $3.77M.

  • Tower Research Capital (TRC)'s largest Q1 2024 buy was iShares S&P Small-Cap 600 Growth ETF: 28,851 shares worth $3.77M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q1 2024, an estimated $61.6M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2024 reduction was Microsoft, cutting an estimated $263M.
  • Tower Research Capital (TRC) fully exited State Street Financial Select Sector SPDR ETF in Q1 2024, selling an estimated $49.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 33% of its $4.15B portfolio in Q1 2024.
  • Tower Research Capital (TRC) opened 470 new positions and closed 532 in Q1 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 49% quarter-over-quarter to $4.15B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.